<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; &#187; Accutane</title>
	<atom:link href="http://blog.lawsuitloanhq.com/blog/tag/accutane/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.lawsuitloanhq.com/blog</link>
	<description></description>
	<lastBuildDate>Fri, 10 Apr 2009 20:57:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
<image>
<link>http://blog.lawsuitloanhq.com/blog</link>
<url>http://blog.lawsuitloanhq.com/blog/wp-content/plugins/maxblogpress-favicon/icons/favicon-2.ico</url>
<title></title>
</image>
		<item>
		<title>We Now Fund Accutane, Avandia, Bextra, Celebrex, Fosamax and more!</title>
		<link>http://blog.lawsuitloanhq.com/blog/2009/04/10/we-now-fund-accutane-avandia-bextra-celebrex-fosamax/</link>
		<comments>http://blog.lawsuitloanhq.com/blog/2009/04/10/we-now-fund-accutane-avandia-bextra-celebrex-fosamax/#comments</comments>
		<pubDate>Fri, 10 Apr 2009 19:36:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[About Lawsuit Funding]]></category>
		<category><![CDATA[Plaintiff Funding]]></category>
		<category><![CDATA[Accutane]]></category>
		<category><![CDATA[Avandia]]></category>
		<category><![CDATA[Bextra]]></category>
		<category><![CDATA[Celebrex]]></category>
		<category><![CDATA[Duragesic Patch]]></category>
		<category><![CDATA[Fosamax]]></category>
		<category><![CDATA[Gadolinium]]></category>
		<category><![CDATA[Kugel Mesh]]></category>
		<category><![CDATA[Ortho Evra]]></category>
		<category><![CDATA[Prempro]]></category>

		<guid isPermaLink="false">http://blog.lawsuitloanhq.com/blog/?p=13</guid>
		<description><![CDATA[You Can Get Cash Now From Your Pharmaceutical Settlement! TriMark Capital Funding, Inc. has exciting news pertaining to a variety of pharmaceutical MDL&#8217;s (multi-district litigation) or class action lawsuits. Wyeth v. Levine was decided by the US Supreme Court on March 4, 2009 . The issue was that of &#8220;pre-emption&#8221;, and it is now considered a moot [...]]]></description>
			<content:encoded><![CDATA[<div>
<h2>You Can Get Cash Now From Your Pharmaceutical Settlement!</h2>
<p>TriMark Capital Funding, Inc. has exciting news pertaining to a variety of pharmaceutical MDL&#8217;s (multi-district litigation) or class action lawsuits.</p>
<p>Wyeth v. Levine was decided by the US Supreme Court on March 4, 2009 . The issue was that of &#8220;pre-emption&#8221;, and it is now considered a moot point. Stated plainly, the Supreme Court has decided that even though drug manufacturers provide a warning label, injured parties can still pursue &#8220;failure to warn&#8221; litigation.</p>
<p>TCF is now moving aggressively funding cash advances on the following pharmaceutical class action lawsuits:</p>
<ul>
<li>Accutane</li>
<li>Avandia</li>
<li>Bextra</li>
<li>Celebrex</li>
<li>Duragesic Patch</li>
<li>Gadolinium</li>
<li>Fosamax</li>
<li>Kugel Mesh</li>
<li>Ortho Evra</li>
<li>Prempro</li>
</ul>
<p>This is a MAJOR breakthrough in litigation financing and TCF is one of the only litigation funding companies in the entire United States currently offering lawsuit cash advances and pre-settlement funding on Accutane, Avandia, Bextra, Celebrex, Duragesic Patch, Gadolinium, Fosamax, Kugel Mesh and Prempro class action lawsuits.</p>
<p>Visit <a title="Lawsuit Loan" href="http://lawsuitloanhq.com/index.htm"  target="_self">LawsuitLoanHQ.com</a> for more information or to apply for a lawsuit cash advance now!</div>
]]></content:encoded>
			<wfw:commentRss>http://blog.lawsuitloanhq.com/blog/2009/04/10/we-now-fund-accutane-avandia-bextra-celebrex-fosamax/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

